Advertisement

Annals of Surgical Oncology

, Volume 25, Issue 11, pp 3280–3287 | Cite as

Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion

  • Shohei Yamaguchi
  • Masaru Morita
  • Manabu Yamamoto
  • Akinori Egashira
  • Hiroyuki Kawano
  • Nao Kinjo
  • Eiji Tsujita
  • Kazuhito Minami
  • Masahiko Ikebe
  • Yasuharu Ikeda
  • Naonobu Kunitake
  • Yasushi Toh
Thoracic Oncology
  • 165 Downloads

Abstract

Background

T4 esophageal cancer (EC) that invades the trachea or bronchus often has poorer prognosis than other T4 ECs. We investigated the long-term results of definitive chemoradiotherapy (dCRT) or induction chemoradiotherapy followed by surgery (iCRT-S) in patients with T4 EC with tracheobronchial invasion (TBI).

Patients and Methods

From 2003 to 2013, 71 patients with T4 EC with TBI were treated in our institution; 58 underwent dCRT, and 13 underwent iCRT-S. The long-term results associated with survival were retrospectively analyzed, and prognostic factors were examined by univariable and multivariable analysis.

Results

The 1-, 2-, and 5-year overall survival for all patients with T4 EC with TBI treated by dCRT or iCRT-S was 57, 29, and 19%, respectively. Multivariable analysis revealed that clinical lymph node (LN) metastasis and the treatment period were significant prognostic factors. Clinical LN positivity had significantly poorer prognosis than LN negativity. The treatment outcome in the later period was significantly better than that in the earlier period. In particular, the outcome after dCRT revealed significantly better prognosis in the later compared with the earlier period, whereas the outcome after iCRT-S did not show such a difference. With respect to treatment modality, no significant difference in survival was observed between dCRT and iCRT-S.

Conclusions

Clinical LN negativity and later treatment period were significantly good prognostic factors for T4 EC with TBI. The recent improvements in dCRT outcomes may help to achieve survival comparable to that of iCRT-S.

Notes

Acknowledgment

We thank Angela Morben, DVM, ELS, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.

References

  1. 1.
    Makino T, Doki Y. Treatment of T4 esophageal cancer. Definitive chemo-radiotherapy vs chemo-radiotherapy followed by surgery. Ann Thorac Cardiovasc Surg. 2011;17:221–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Fujita H. A history of surgery for locally-advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective. Ann Thorac Cardiovasc Surg. 2013;19:409–15.CrossRefPubMedGoogle Scholar
  3. 3.
    Akutsu Y, Matsubara H. Chemoradiotherapy and surgery for T4 esophageal cancer in Japan. Surg Today. 2015;45:1360–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Seto Y, Chin K, Gomi K, et al. Treatment of thoracic esophageal carcinoma invading adjacent structures. Cancer Sci. 2007;98:937–42.CrossRefPubMedGoogle Scholar
  5. 5.
    Fujita H, Sueyoshi S, Tanaka T, et al. Esophagectomy: is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery. World J Surg. 2005;29:25–30.CrossRefPubMedGoogle Scholar
  6. 6.
    Morita M, Toh Y, Saeki H, et al. Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer. Anticancer Res. 2012;32:3275–82.PubMedGoogle Scholar
  7. 7.
    Ohtsu A, Yoshida S, Boku N, et al. Concurrent chemotherapy and radiation therapy for locally advanced carcinoma of the esophagus. J Clin Oncol. 1995;25:261–6.Google Scholar
  8. 8.
    Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–21.CrossRefPubMedGoogle Scholar
  9. 9.
    Itoh Y, Fuwa N, Matsumoto A, Asano A, Morita K. Outcomes of radiotherapy of inoperable locally advanced (T4) esophageal cancer-retrospective analysis. Radiat Med. 2001;19:231–5.PubMedGoogle Scholar
  10. 10.
    Nishimura Y, Suzuki M, Nakamatsu K, Kanamori S, Yagyu Y, Shigeoka H. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys. 2002;53:134–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Kaneko K, Ito H, Konishi K, et al. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus. Br J Cancer. 2003;88:18–24.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Crosby TD, Brewster AE, Borley A, Perschky L, Kehagioglou P, Court J, Maughan TS. Definitive chemoradiation in patients with inoperable oesopahgeal carcinoma. Br J Cancer. 2004;90:70–5.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol. 2004;34:615–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Font A, Arellano A, Fernandez-Llamazares J, et al. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer. Clin Transl Oncol. 2007;9:177–82.CrossRefPubMedGoogle Scholar
  15. 15.
    Yano M, Tsujinaka T, Shiozaki H, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol. 1999;70:25–32.CrossRefPubMedGoogle Scholar
  16. 16.
    Ikeda K, Ishida K, Sato N, et al. Chemoradiothearapy followed by surgery for thoracic esophageal cancer potentially of actually involving adjacent organs. Dis Esophagus. 2001;14:197–201.CrossRefPubMedGoogle Scholar
  17. 17.
    Noguchi T, Moriyama H, Wada S, Takeno S, Wakisaka M, Mori H, Uchida Y. Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma. Dis Esophagus. 2003;16:94–8.CrossRefPubMedGoogle Scholar
  18. 18.
    de Manzoni G, Pedrazzani C, Pasini F et al. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. J Surg Oncol. 2007;95:261–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Miyoshi N, Yano M, Takachi K, et al. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer. J Surg Oncol. 2009;99:302–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Pimiento JM, Weber J, Hoffe SE, et al. Outcomes associated with surgery for T4 esophageal cancer. Ann Surg Oncol. 2013;20(8):2706–12.CrossRefPubMedGoogle Scholar
  21. 21.
    Shimoji H, Karimasa H, Nagahama M, Nishimaki T. Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study. World J Surg. 2013;37:2180–8.CrossRefPubMedGoogle Scholar
  22. 22.
    The Japan Esophageal Society. Japanese classification of esophageal cancer (the 11th edition, revised version). Tokyo: Kanehara; 2015.Google Scholar
  23. 23.
    Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, Shiozaki H. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009;23:73–80.CrossRefPubMedGoogle Scholar
  24. 24.
    Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Yano M, Shiozaki H, Tsujinaka T, Inoue M, Doki Y, Fujiwara Y, Monden M. Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy. J Am Coll Surg. 2000;191:626–34.CrossRefPubMedGoogle Scholar
  26. 26.
    Karimata H, Shimoji H, Nishimaki T. Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy. Surg Today. 2015;45:479–86.CrossRefPubMedGoogle Scholar
  27. 27.
    Ito H, Itasaka S, Sakanaka K, Araki N, Mizowaki T, Hiraoka M. Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method. J Radiat Res. 2017;58:106–13.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Mackley HB, Adelstein JS, Reddy CA, Adelstein DJ, Rice TW, Saxton JP, Videtic GM. Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer. J Gastrointest Cancer. 2008;39:130–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Lin SH, Wang L, Myles B, et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;84:1078–85.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with or without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310–7.CrossRefPubMedGoogle Scholar
  31. 31.
    Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–8.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Shohei Yamaguchi
    • 1
    • 2
  • Masaru Morita
    • 1
  • Manabu Yamamoto
    • 1
  • Akinori Egashira
    • 1
  • Hiroyuki Kawano
    • 1
  • Nao Kinjo
    • 1
  • Eiji Tsujita
    • 1
  • Kazuhito Minami
    • 1
  • Masahiko Ikebe
    • 1
  • Yasuharu Ikeda
    • 1
  • Naonobu Kunitake
    • 3
  • Yasushi Toh
    • 1
  1. 1.Department of Gastroenterological SurgeryNational Kyushu Cancer CenterFukuokaJapan
  2. 2.Department of SurgeryHiroshima Red Cross Hospital & Atomic-bomb Survivors HospitalHiroshimaJapan
  3. 3.Department of RadiologyNational Kyushu Cancer CenterFukuokaJapan

Personalised recommendations